These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 524372)

  • 21. The comparative toxicology of ethyl- and methylmercury.
    Magos L; Brown AW; Sparrow S; Bailey E; Snowden RT; Skipp WR
    Arch Toxicol; 1985 Sep; 57(4):260-7. PubMed ID: 4091651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early treatment of so-called "a frigore" facial paralysis with chelating agents].
    Hennebert PE
    Acta Otorhinolaryngol Belg; 1973; 27(1):75-8. PubMed ID: 4697139
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Rummel KT; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Observations on the internal decontamination of radioelements].
    Brenot A; Chiadot P; Rinaldi R
    Ann Biol Clin (Paris); 1966; 24(10):1223-30. PubMed ID: 5983186
    [No Abstract]   [Full Text] [Related]  

  • 25. Heavy metals and the nervous system.
    Greenhouse AH
    Clin Neuropharmacol; 1982; 5(1):45-92. PubMed ID: 6807541
    [No Abstract]   [Full Text] [Related]  

  • 26. The uptake of methyl mercury (203Hg) in different tissues related to its neurotoxic effects.
    Somjen GG; Herman SP; Klein R; Brubaker PE; Briner WH; Goodrich JK; Krigman MR; Haseman JK
    J Pharmacol Exp Ther; 1973 Dec; 187(3):602-11. PubMed ID: 4770401
    [No Abstract]   [Full Text] [Related]  

  • 27. Chelating agents in medicine.
    Williams DR; Halstead BW
    J Toxicol Clin Toxicol; 1982 Dec; 19(10):1081-115. PubMed ID: 6820958
    [No Abstract]   [Full Text] [Related]  

  • 28. Methylmercury poisoning in mothers and their suckling infants.
    Amin-Zaki L; Elhassani SB; Majeed MA; Clarkson TW; Doherty RA; Greenwood MR
    Dev Toxicol Environ Sci; 1980; 8():75-8. PubMed ID: 6171399
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of the neurologic manifestations of Wilson's disease.
    Scheinberg IH; Sternlieb I
    Arch Neurol; 1995 Apr; 52(4):339-40. PubMed ID: 7710368
    [No Abstract]   [Full Text] [Related]  

  • 30. Methylmercury: exposure duration and regional distribution as determinants of neurotoxicity in nonhuman primates.
    Evans HL; Garman RH; Weiss B
    Toxicol Appl Pharmacol; 1977 Jul; 41(1):15-33. PubMed ID: 408941
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the influence of chelating agents on the excretion and the behavior of mercury in acute mercury poisoning].
    Eybl V; Sýkora J; Mertl F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):79-84. PubMed ID: 4222871
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical response to therapeutic agents in poisoning from mercury vapor.
    Sunderman FW
    Ann Clin Lab Sci; 1978; 8(4):259-69. PubMed ID: 210702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of mercaptodextran on distribution and toxicity of mercury in mice.
    Aaseth J
    Acta Pharmacol Toxicol (Copenh); 1973; 32(6):430-41. PubMed ID: 4800750
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contamination of the environment with mercury--its health problems. II. Toxic effects of mercury and its compounds].
    Ludwicki JK
    Rocz Panstw Zakl Hig; 1985; 36(1):1-8. PubMed ID: 3895371
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study of the sensitivity of virgin and pregnant rats to methylmercury.
    Magos L; Peristianis GC; Clarkson TW; Snowden RT; Majeed MA
    Arch Toxicol; 1980 Feb; 43(4):283-91. PubMed ID: 7387388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of N-acetylpenicillamine on the distribution of methyl mercury and inorganic mercury in mice.
    Aaseth J
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():422-6. PubMed ID: 302601
    [No Abstract]   [Full Text] [Related]  

  • 38. Minamata disease: what is a keystone of its molecular mechanism? A biochemical theory on the nature of methyl mercury neurotoxicity.
    Kuznetsov DA
    Int J Neurosci; 1990 Jul; 53(1):1-51. PubMed ID: 2269614
    [No Abstract]   [Full Text] [Related]  

  • 39. Accumulation and tissue distribution of mercury in the guinea pig during subacute administration of methyl mercury.
    Iverson F; Downie RH; Trenholm HL; Paul C
    Toxicol Appl Pharmacol; 1974 Jan; 27(1):60-9. PubMed ID: 4152756
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of acute lead intoxication--choice of chelating agents and supportive therapeutic measures.
    Chisolm JJ
    Clin Toxicol; 1970 Dec; 3(4):527-40. PubMed ID: 4999705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.